Immune Response Modifiers
DBCAT005712Pharmacologic class
Agents that modify immune responses to exert their therapeutic effect(s). A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of November 29, 2022
Which targets do Immune Response Modifiers share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account